Lieu évènementiel, 2-4 Imp. Lamier, 75011 Paris, France, PARIS, France, 75011 Paris
Advertisements
Upcoming events at this venue
The National Running Show at National Exhibition Centre
#_EVENTSTARTDATE
25 Jan - 26 Jan 2025, 9:00 am - 5:00 pm
This is the biggest community meet-up of the year and perfectly timed for runners that are training...
3rd Medical Device Software Development Summit Europe
#_EVENTSTARTDATE
27 Jan - 29 Jan 2025, 8:00 am - 5:00 pm
Integrating Expertise from Software Development, Quality Assurance, Regulatory Affairs, and Product Teams to Drive Innovation in Alignment...
LEAP HR: Higher Education 2025
#_EVENTSTARTDATE
27 Jan - 29 Jan 2025, 12:00 pm - 2:20 pm
Mark your calendars for the return of LEAP HR: Higher Education taking place from January 27-29 in...
Fifth International conference on creativity and innovation at/for/from/with grassroots [ICCIG 5]
#_EVENTSTARTDATE
28 Jan - 30 Jan 2025, All Day
The ICCIG aims to bring together a diverse group of individuals and organizations to share and discuss...
3rd Molecular Glue Drug Development Summit
#_EVENTSTARTDATE
28 Jan - 30 Jan 2025, 8:00 am - 4:45 pm
Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a...
4th mRNA-Based Therapeutics Summit Europe
#_EVENTSTARTDATE
28 Jan - 30 Jan 2025, 8:00 am - 5:00 pm
With GSK's €1.4Bn investment into acquiring CureVac's infectious disease pipeline, Moderna and BioNTech's initiation of personalised cancer...
6th RNAi-Based Therapeutics Summit
#_EVENTSTARTDATE
28 Jan - 30 Jan 2025, 8:00 am - 6:00 pm
As innovative drug delivery platforms beyond GalNac continue to emerge and novel chemical modifications are discovered, the...
ENT Updates 2025
#_EVENTSTARTDATE
29 Jan - 01 Feb 2025, 7:00 am - 12:00 pm
ENT Updates 2025 is a specialized conference that offers an extensive and thorough examination of the latest...
9th Tumor Models San Francisco Summit 2025
#_EVENTSTARTDATE
29 Jan - 30 Jan 2025, 8:00 am - 2:30 pm
Waves of new models are being validated. A wider industry shift to precision oncology is requiring more...